You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ixazomib

Showing 1 - 25 of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Hangzhou (Ixazomib plus low-dose lenalidomide, Ixazomib)

Recruiting
  • Multiple Myeloma
  • Ixazomib plus low-dose lenalidomide
  • Ixazomib
  • Hangzhou, Zhejiang, China
    Yang Xu
Feb 9, 2023

Mantle Cell Lymphoma Trial in Busan (Ixazomib)

Recruiting
  • Mantle Cell Lymphoma
  • Ixazomib
  • Busan, Western, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
  • +3 more
Jan 5, 2022

Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Ixazomib
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 15, 2022

Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 16, 2021

Multiple Myeloma Trial in Beijing (Ixazomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Beijing, Beijing, China
    PekingUMCH
Nov 30, 2021

Relapsed/Refractory Multiple Myeloma Trial in La Jolla (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Ixazomib
  • +3 more
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 7, 2022

Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Ixazomib
  • Rituximab
  • Atlanta, Georgia
  • +1 more
Oct 26, 2021

Mantle-Cell Lymphoma Trial in United States (Ixazomib, Ibrutinib)

Active, not recruiting
  • Mantle-Cell Lymphoma
  • Atlanta, Georgia
  • +13 more
Mar 31, 2022

Systemic Sclerosis, Scleroderma, Diffuse Systemic Sclerosis Trial in Scottsdale (Ixazomib)

Recruiting
  • Systemic Sclerosis
  • +18 more
  • Ixazomib
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
May 3, 2022

Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma
  • Ixazomib
  • +3 more
  • Badalona, Spain
  • +7 more
May 20, 2022

Myeloma, Multiple Trial in United States (Lenalidomide, Ixazomib, Daratumumab Injection)

Recruiting
  • Myeloma, Multiple
  • Bangor, Maine
  • +7 more
Mar 10, 2022

AL Amyloidosis Trial in United States (Ixazomib, Dexamethasone)

Recruiting
  • AL Amyloidosis
  • Boston, Massachusetts
  • +7 more
Jan 21, 2022

Glioblastoma Trial in Atlanta (Ixazomib)

Completed
Has Results
  • Glioblastoma
  • Ixazomib
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Mar 2, 2021

Myeloid Hematologic Malignancy, Lymphoid Hematologic Malignancy Trial in New York (Ixazomib)

Completed
  • Myeloid Hematologic Malignancy
  • Lymphoid Hematologic Malignancy
  • Ixazomib
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 3, 2021

Multiple Myeloma at First Relapse Trial in France (Ixazomib, Iberdomide, Dexamethasone Oral)

Recruiting
  • Multiple Myeloma at First Relapse
  • Ixazomib
  • +2 more
  • Annecy, France
  • +20 more
Dec 16, 2021

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Boston, Danvers, Newton (Nivolumab, Ixazomib, Dexamethasone)

Active, not recruiting
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Boston, Massachusetts
  • +2 more
May 14, 2021

Multiple Myeloma Trial in Worldwide (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Helsinki, Finland
  • +25 more
Mar 14, 2022

Newly Diagnosed Multiple Myeloma Trial in West Hollywood (Ixazomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • West Hollywood, California
    James R Berenson, MD, Inc.
Oct 23, 2020

Multiple Myeloma Trial in Odense (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • Odense, Denmark
    Odense University Hospital
Nov 18, 2021

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2021

Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Bortezomib, Carfilzomib)

Completed
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Ixazomib
  • +4 more
  • Kamogawa, Chiba, Japan
  • +22 more
Jul 27, 2022

Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)

Completed
Has Results
  • Multiple Myeloma
  • Allogeneic HSCT
  • +5 more
  • Birmingham, Alabama
  • +14 more
Jan 25, 2022

Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Ixazomib
  • Atlanta, Georgia
  • +23 more
Dec 20, 2021

Multiple Myeloma Trial in Toulouse (Ixazomib, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Toulouse, France
    University Hosptial Toulouse
Nov 9, 2020